Summary

The global allergy shots market is poised for substantial growth over the coming years, driven by increasing prevalence of allergic conditions and the growing need for long-term, effective treatment solutions. According to market projections, the global allergy shots market is expected to grow from US$ 3.1 billion in 2025 to US$ 6.1 billion by 2032, expanding at a robust CAGR of 10.15% during the forecast period.

Market Insights

Allergy shots, also known as allergen immunotherapy, offer long-term relief by desensitizing the immune system to specific allergens such as pollen, dust mites, pet dander, insect venom, and mold. Unlike symptomatic treatments, these injections target the root cause of allergic reactions, offering a more permanent solution for many patients. They function similarly to vaccines by gradually building the immune system’s tolerance to allergens through regular and increasing doses.

This form of treatment is increasingly favored among patients suffering from persistent and severe allergic rhinitis, asthma, and insect venom hypersensitivity. Allergy shots are shown to reduce the need for long-term medication, provide symptom relief even after discontinuation, and prevent the progression of allergic diseases.

Market Drivers

A significant driver for the allergy shots market is the rising incidence of various allergy types globally. Environmental changes, increasing air pollution, urbanization, and shifts in dietary patterns have all contributed to a growing number of allergy cases. According to various global health estimates, allergic rhinitis affects up to 30% of the population in certain regions.

Additionally, continuous innovation in allergen-specific immunotherapies, including recombinant and synthetic formulations, is enhancing the effectiveness of allergy shots. Biotechnology companies are developing faster-acting and more precise solutions to improve patient adherence and outcomes. Increasing awareness about allergy prevention and long-term treatment benefits also plays a key role in shaping market trends.

Business Opportunity

The allergy shots market presents lucrative opportunities for companies investing in research and product development. Strategic mergers, collaborations, and acquisitions are commonly adopted by key market players to expand their therapeutic portfolios and geographic presence.

For instance, partnerships like the one between Aimmune Therapeutics and Allergy Partners aim to increase access to specialized food allergy treatments through national networks. Similarly, Anergis’ collaboration with Virometix to explore synthetic virus-like particles highlights the sector’s push toward next-generation immunotherapies.

Regional Analysis

The United States continues to dominate the North American allergy shots market due to increased investment in healthcare R&D, rising allergy prevalence, and supportive government funding. The region benefits from a well-established network of allergists and immunologists offering specialized treatment services.

Germany leads the European market with a strong focus on product innovation and accessibility. For example, the launch of ITULAZAX, a convenient once-daily sublingual tablet for tree pollen allergies, has strengthened Germany’s market position.

In Asia, Japan is emerging as a key market owing to the high prevalence of seasonal allergies, particularly those linked to cedar pollen. The regional market benefits from ongoing epidemiological studies and efforts to enhance treatment protocols for widespread allergic conditions.

Key Players

The global allergy shots market is consolidated with a few major players leading through innovation and expansion strategies. Notable companies include:

• ALK Abello

• Stallergenes Greer

• Allergy Therapeutics

• Aimmune Therapeutics

• Anergis

• Arrayit Corporation

• Biomay AG

• HAL Allergy Group

• DBV Technologies

These players are actively involved in clinical trials, product development, and regional collaborations aimed at improving patient accessibility and therapeutic efficiency.

Segmentation

By Product:

• Injections

• Sublingual Immunotherapy (SLIT)

By Immunotherapy Type:

• Subcutaneous Immunotherapy (SCIT)

• Sublingual Immunotherapy (SLIT)

By Indication:

• Allergic Rhinitis

• Allergic Asthma

• Venom Allergy

• Food Allergy

• Others

By Allergen Type:

• Pollen

• Dust Mites

• Pet Dander

• Mold

• Insect Venom

• Others

By Distribution Channel:

• Institutional Sales (Government Hospitals, Semi-Government Hospitals, Private Hospitals)

• Retail Sales (Pharmacies, Online Pharmacies)

By Region:

• North America

• Europe

• East Asia

• South Asia & Pacific

• Latin America

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary

1.1. Global Allergy Shots Market Snapshot

1.2. Future Projections

1.3. Key Market Trends

1.4. Regional Snapshot, by Value and Volume, 2025

1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations

2.2. Market Dynamics

2.2.1. Drivers

2.2.2. Restraints

2.2.3. Market Opportunities

2.3. Value Chain Analysis

2.4. Porter’s Five Forces Analysis

2.5. COVID-19 Impact Analysis

2.5.1. Supply

2.5.2. Demand

2.6. Impact of Ukraine-Russia Conflict

2.7. Economic Overview

2.7.1. World Economic Projections

2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2019-2023

3.1. Global Allergy Shots Market Production Output, by Region, Value (US$ Bn) and Volume (‘000 Units), 2019-2023

3.1.1. North America

3.1.2. Europe

3.1.3. Asia Pacific

3.1.4. Latin America

3.1.5. Middle East and Africa

4. Price Analysis, 2019-2023

4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2019-2023

4.2. Prominent Factor Affecting Allergy Shots Prices

4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Allergy Shots Market Outlook, 2019-2032

5.1. Global Allergy Shots Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032

5.1.1. Key Highlights

5.1.1.1. SLIT Tablets

5.1.1.1.1. Odactra

5.1.1.1.2. Grastek

5.1.1.1.3. Ragwitek

5.1.1.1.4. Oralair

5.1.1.1.5. Actair

5.1.1.1.6. Others

5.1.1.2. Oral

5.1.1.2.1. Palforzia

5.1.1.2.2. Others

5.1.1.3. Injections

5.1.1.4. Others

5.2. Global Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

5.2.1. Key Highlights

5.2.1.1. Sublingual Immunotherapy (SLIT)

5.2.1.2. Subcutaneous Immunotherapy (SCIT)

5.2.1.2.1. Specific Immunotherapy

5.2.1.3. Others

5.3. Global Allergy Shots Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

5.3.1. Key Highlights

5.3.1.1. Allergic Rhinitis

5.3.1.2. Allergic Asthma

5.3.1.3. Food Allergy

5.3.1.4. Atopic Dermatitis

5.3.1.5. Others

5.4. Global Allergy Shots Market Outlook, by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

5.4.1. Key Highlights

5.4.1.1. Pollens

5.4.1.1.1. Grass Pollens

5.4.1.1.2. Weed Pollens

5.4.1.1.3. Tree Pollens

5.4.1.2. House Dust Mites (HDM)

5.4.1.3. Mold

5.4.1.4. Animal Dander

5.4.1.5. Bee Venom

5.4.1.6. Cockroaches/Insects

5.4.1.7. Others

5.5. Others Global Allergy Shots Market Outlook, by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

5.5.1. Key Highlights

5.5.1.1. Institutional Sales

5.5.1.1.1. Government Hospitals

5.5.1.1.2. Semi-Government Hospitals

5.5.1.1.3. Private Hospitals

5.5.1.2. Retail Sales

5.5.1.2.1. Retail Pharmacy

5.5.1.2.2. Drug Stores

5.5.1.2.3. Online Pharmacy

5.6. Global Allergy Shots Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019-2032

5.6.1. Key Highlights

5.6.1.1. North America

5.6.1.2. Europe

5.6.1.3. Asia Pacific

5.6.1.4. Latin America

5.6.1.5. Middle East & Africa

6. North America Allergy Shots Market Outlook, 2019-2032

6.1. North America Allergy Shots Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032

6.1.1. Key Highlights

6.1.1.1. SLIT Tablets

6.1.1.1.1. Odactra

6.1.1.1.2. Grastek

6.1.1.1.3. Ragwitek

6.1.1.1.4. Oralair

6.1.1.1.5. Actair

6.1.1.1.6. Others

6.1.1.2. Oral

6.1.1.2.1. Palforzia

6.1.1.2.2. Others

6.1.1.3. Injections

6.1.1.4. Others

6.2. North America Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

6.2.1. Key Highlights

6.2.1.1. Sublingual Immunotherapy (SLIT)

6.2.1.2. Subcutaneous Immunotherapy (SCIT)

6.2.1.2.1. Specific Immunotherapy

6.2.1.3. Others

6.3. North America Allergy Shots Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

6.3.1. Key Highlights

6.3.1.1. Allergic Rhinitis

6.3.1.2. Allergic Asthma

6.3.1.3. Food Allergy

6.3.1.4. Atopic Dermatitis

6.3.1.5. Others

6.4. North America Allergy Shots Market Outlook, by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

6.4.1. Key Highlights

6.4.1.1. Pollens

6.4.1.1.1. Grass Pollens

6.4.1.1.2. Weed Pollens

6.4.1.1.3. Tree Pollens

6.4.1.2. House Dust Mites (HDM)

6.4.1.3. Mold

6.4.1.4. Animal Dander

6.4.1.5. Bee Venom

6.4.1.6. Cockroaches/Insects

6.4.1.7. Others

6.5. North America Allergy Shots Market Outlook, by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

6.5.1. Key Highlights

6.5.1.1. Institutional Sales

6.5.1.1.1. Government Hospitals

6.5.1.1.2. Semi-Government Hospitals

6.5.1.1.3. Private Hospitals

6.5.1.2. Retail Sales

6.5.1.2.1. Retail Pharmacy

6.5.1.2.2. Drug Stores

6.5.1.2.3. Online Pharmacy

6.5.2. BPS Analysis/Market Attractiveness Analysis

6.6. North America Allergy Shots Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032

6.6.1. Key Highlights

6.6.1.1. U.S. Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

6.6.1.2. U.S. Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

6.6.1.3. U.S. Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

6.6.1.4. U.S. Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

6.6.1.5. U.S. Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

6.6.1.6. Canada Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

6.6.1.7. Canada Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

6.6.1.8. Canada Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

6.6.1.9. Canada Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

6.6.1.10. Canada Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Allergy Shots Market Outlook, 2019-2032

7.1. Europe Allergy Shots Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032

7.1.1. Key Highlights

7.1.1.1. SLIT Tablets

7.1.1.1.1. Odactra

7.1.1.1.2. Grastek

7.1.1.1.3. Ragwitek

7.1.1.1.4. Oralair

7.1.1.1.5. Actair

7.1.1.1.6. Others

7.1.1.2. Oral

7.1.1.2.1. Palforzia

7.1.1.2.2. Others

7.1.1.3. Injections

7.1.1.4. Others

7.2. Europe Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

7.2.1. Key Highlights

7.2.1.1. Sublingual Immunotherapy (SLIT)

7.2.1.2. Subcutaneous Immunotherapy (SCIT)

7.2.1.2.1. Specific Immunotherapy

7.2.1.3. Others

7.3. Europe Allergy Shots Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

7.3.1. Key Highlights

7.3.1.1. Allergic Rhinitis

7.3.1.2. Allergic Asthma

7.3.1.3. Food Allergy

7.3.1.4. Atopic Dermatitis

7.3.1.5. Others

7.4. Europe Allergy Shots Market Outlook, by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

7.4.1. Key Highlights

7.4.1.1. Pollens

7.4.1.1.1. Grass Pollens

7.4.1.1.2. Weed Pollens

7.4.1.1.3. Tree Pollens

7.4.1.2. House Dust Mites (HDM)

7.4.1.3. Mold

7.4.1.4. Animal Dander

7.4.1.5. Bee Venom

7.4.1.6. Cockroaches/Insects

7.4.1.7. Others

7.5. Europe Allergy Shots Market Outlook, by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

7.5.1. Key Highlights

7.5.1.1. Institutional Sales

7.5.1.1.1. Government Hospitals

7.5.1.1.2. Semi-Government Hospitals

7.5.1.1.3. Private Hospitals

7.5.1.2. Retail Sales

7.5.1.2.1. Retail Pharmacy

7.5.1.2.2. Drug Stores

7.5.1.2.3. Online Pharmacy

7.5.2. BPS Analysis/Market Attractiveness Analysis

7.6. Europe Allergy Shots Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1. Key Highlights

7.6.1.1. Germany Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.2. Germany Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.3. Germany Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.4. Germany Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.5. Germany Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.6. U.K. Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.7. U.K. Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.8. U.K. Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.9. U.K. Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.10. U.K. Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.11. France Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.12. France Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.13. France Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.14. France Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.15. France Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.16. Italy Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.17. Italy Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.18. Italy Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.19. Italy Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.20. Italy Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.21. Turkey Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.22. Turkey Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.23. Turkey Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.24. Turkey Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.25. Turkey Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.26. Russia Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.27. Russia Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.28. Russia Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.29. Russia Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.30. Russia Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.31. Rest of Europe Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.32. Rest of Europe Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.33. Rest of Europe Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.34. Rest of Europe Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.1.35. Rest of Europe Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Allergy Shots Market Outlook, 2019-2032

8.1. Asia Pacific Allergy Shots Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032

8.1.1. Key Highlights

8.1.1.1. SLIT Tablets

8.1.1.1.1. Odactra

8.1.1.1.2. Grastek

8.1.1.1.3. Ragwitek

8.1.1.1.4. Oralair

8.1.1.1.5. Actair

8.1.1.1.6. Others

8.1.1.2. Oral

8.1.1.2.1. Palforzia

8.1.1.2.2. Others

8.1.1.3. Injections

8.1.1.4. Others

8.2. Asia Pacific Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

8.2.1. Key Highlights

8.2.1.1. Sublingual Immunotherapy (SLIT)

8.2.1.2. Subcutaneous Immunotherapy (SCIT)

8.2.1.2.1. Specific Immunotherapy

8.2.1.3. Others

8.3. Asia Pacific Allergy Shots Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

8.3.1. Key Highlights

8.3.1.1. Allergic Rhinitis

8.3.1.2. Allergic Asthma

8.3.1.3. Food Allergy

8.3.1.4. Atopic Dermatitis

8.3.1.5. Others

8.4. Asia Pacific Allergy Shots Market Outlook, by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

8.4.1. Key Highlights

8.4.1.1. Pollens

8.4.1.1.1. Grass Pollens

8.4.1.1.2. Weed Pollens

8.4.1.1.3. Tree Pollens

8.4.1.2. House Dust Mites (HDM)

8.4.1.3. Mold

8.4.1.4. Animal Dander

8.4.1.5. Bee Venom

8.4.1.6. Cockroaches/Insects

8.4.1.7. Others

8.5. Asia Pacific Allergy Shots Market Outlook, by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

8.5.1. Key Highlights

8.5.1.1. Institutional Sales

8.5.1.1.1. Government Hospitals

8.5.1.1.2. Semi-Government Hospitals

8.5.1.1.3. Private Hospitals

8.5.1.2. Retail Sales

8.5.1.2.1. Retail Pharmacy

8.5.1.2.2. Drug Stores

8.5.1.2.3. Online Pharmacy

8.5.2. BPS Analysis/Market Attractiveness Analysis

8.6. Asia Pacific Allergy Shots Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1. Key Highlights

8.6.1.1. China Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.2. China Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.3. China Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.4. China Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.5. China Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.6. Japan Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.7. Japan Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.8. Japan Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.9. Japan Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.10. Japan Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.11. South Korea Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.12. South Korea Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.13. South Korea Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.14. South Korea Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.15. South Korea Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.16. India Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.17. India Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.18. India Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.19. India Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.20. India Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.21. Southeast Asia Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.22. Southeast Asia Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.23. Southeast Asia Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.24. Southeast Asia Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.25. Southeast Asia Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.26. Rest of Asia Pacific Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.27. Rest of Asia Pacific Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.28. Rest of Asia Pacific Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.29. Rest of Asia Pacific Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.1.30. Rest of Asia Pacific Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

8.6.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Allergy Shots Market Outlook, 2019-2032

9.1. Latin America Allergy Shots Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032

9.1.1. Key Highlights

9.1.1.1. SLIT Tablets

9.1.1.1.1. Odactra

9.1.1.1.2. Grastek

9.1.1.1.3. Ragwitek

9.1.1.1.4. Oralair

9.1.1.1.5. Actair

9.1.1.1.6. Others

9.1.1.2. Oral

9.1.1.2.1. Palforzia

9.1.1.2.2. Others

9.1.1.3. Injections

9.1.1.4. Others

9.2. Latin America Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

9.2.1.1. Sublingual Immunotherapy (SLIT)

9.2.1.2. Subcutaneous Immunotherapy (SCIT)

9.2.1.2.1. Specific Immunotherapy

9.2.1.3. Others

9.3. Latin America Allergy Shots Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

9.3.1. Key Highlights

9.3.1.1. Allergic Rhinitis

9.3.1.2. Allergic Asthma

9.3.1.3. Food Allergy

9.3.1.4. Atopic Dermatitis

9.3.1.5. Others

9.4. Latin America Allergy Shots Market Outlook, by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

9.4.1. Key Highlights

9.4.1.1. Pollens

9.4.1.1.1. Grass Pollens

9.4.1.1.2. Weed Pollens

9.4.1.1.3. Tree Pollens

9.4.1.2. House Dust Mites (HDM)

9.4.1.3. Mold

9.4.1.4. Animal Dander

9.4.1.5. Bee Venom

9.4.1.6. Cockroaches/Insects

9.4.1.7. Others

9.5. Latin America Allergy Shots Market Outlook, by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

9.5.1. Key Highlights

9.5.1.1. Institutional Sales

9.5.1.1.1. Government Hospitals

9.5.1.1.2. Semi-Government Hospitals

9.5.1.1.3. Private Hospitals

9.5.1.2. Retail Sales

9.5.1.2.1. Retail Pharmacy

9.5.1.2.2. Drug Stores

9.5.1.2.3. Online Pharmacy

9.5.2. BPS Analysis/Market Attractiveness Analysis

9.6. Latin America Allergy Shots Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1. Key Highlights

9.6.1.1. Brazil Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.2. Brazil Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.3. Brazil Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.4. Brazil Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.5. Brazil Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.6. Mexico Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.7. Mexico Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.8. Mexico Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.9. Mexico Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.10. Mexico Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.11. Argentina Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.12. Argentina Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.13. Argentina Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.14. Argentina Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.15. Argentina Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.16. Rest of Latin America Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.17. Rest of Latin America Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.18. Rest of Latin America Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.19. Rest of Latin America Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.1.20. Rest of Latin America Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

9.6.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Allergy Shots Market Outlook, 2019-2032

10.1. Middle East & Africa Allergy Shots Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032

10.1.1. Key Highlights

10.1.1.1. SLIT Tablets

10.1.1.1.1. Odactra

10.1.1.1.2. Grastek

10.1.1.1.3. Ragwitek

10.1.1.1.4. Oralair

10.1.1.1.5. Actair

10.1.1.1.6. Others

10.1.1.2. Oral

10.1.1.2.1. Palforzia

10.1.1.2.2. Others

10.1.1.3. Injections

10.1.1.4. Others

10.2. Middle East & Africa Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

10.2.1. Key Highlights

10.2.1.1. Sublingual Immunotherapy (SLIT)

10.2.1.2. Subcutaneous Immunotherapy (SCIT)

10.2.1.2.1. Specific Immunotherapy

10.2.1.3. Others

10.3. Middle East & Africa Allergy Shots Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

10.3.1. Key Highlights

10.3.1.1. Allergic Rhinitis

10.3.1.2. Allergic Asthma

10.3.1.3. Food Allergy

10.3.1.4. Atopic Dermatitis

10.3.1.5. Others

10.4. Middle East & Africa Allergy Shots Market Outlook, by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

10.4.1. Key Highlights

10.4.1.1. Cell Wall Synthesis Inhibitors

10.4.1.2. Protein Synthesis Inhibitors

10.4.1.3. DNA Synthesis Inhibitors

10.4.1.4. RNA Synthesis Inhibitors

10.4.1.5. Others

10.5. Middle East & Africa Allergy Shots Market Outlook, by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

10.5.1. Key Highlights

10.5.1.1. Institutional Sales

10.5.1.1.1. Government Hospitals

10.5.1.1.2. Semi-Government Hospitals

10.5.1.1.3. Private Hospitals

10.5.1.2. Retail Sales

10.5.1.2.1. Retail Pharmacy

10.5.1.2.2. Drug Stores

10.5.1.2.3. Online Pharmacy

10.5.2. BPS Analysis/Market Attractiveness Analysis

10.6. Middle East & Africa Allergy Shots Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1. Key Highlights

10.6.1.1. GCC Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.2. GCC Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.3. GCC Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.4. GCC Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.5. GCC Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.6. South Africa Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.7. South Africa Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.8. South Africa Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.9. South Africa Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.10. South Africa Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.11. Egypt Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.12. Egypt Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.13. Egypt Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.14. Egypt Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.15. Egypt Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.16. Nigeria Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.17. Nigeria Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.18. Nigeria Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.19. Nigeria Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.20. Nigeria Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.21. Rest of Middle East & Africa Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.22. Rest of Middle East & Africa Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.23. Rest of Middle East & Africa Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.24. Rest of Middle East & Africa Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.1.25. Rest of Middle East & Africa Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032

10.6.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

11.1. By Species vs by Immunotherapy Heat map

11.2. Manufacturer vs by Immunotherapy Heat map

11.3. Company Market Share Analysis, 2025

11.4. Competitive Dashboard

11.5. Company Profiles

11.5.1. Stallergenes Greer

11.5.1.1. Company Overview

11.5.1.2. Product Portfolio

11.5.1.3. Financial Overview

11.5.1.4. Business Strategies and Development

11.5.2. Allergy Therapeutics

11.5.2.1. Company Overview

11.5.2.2. Product Portfolio

11.5.2.3. Financial Overview

11.5.2.4. Business Strategies and Development

11.5.3. Aimmune Therapeutics

11.5.3.1. Company Overview

11.5.3.2. Product Portfolio

11.5.3.3. Financial Overview

11.5.3.4. Business Strategies and Development

11.5.4. Anergis

11.5.4.1. Company Overview

11.5.4.2. Product Portfolio

11.5.4.3. Financial Overview

11.5.4.4. Business Strategies and Development

11.5.5. Arrayit Corporation

11.5.5.1. Company Overview

11.5.5.2. Product Portfolio

11.5.5.3. Financial Overview

11.5.5.4. Business Strategies and Development

11.5.6. Biomay AG

11.5.6.1. Company Overview

11.5.6.2. Product Portfolio

11.5.6.3. Financial Overview

11.5.6.4. Business Strategies and Development

11.5.7. HAL Allergy Group

11.5.7.1. Company Overview

11.5.7.2. Product Portfolio

11.5.7.3. Financial Overview

11.5.7.4. Business Strategies and Development

11.5.8. DBV Technologies

11.5.8.1. Company Overview

11.5.8.2. Product Portfolio

11.5.8.3. Financial Overview

11.5.8.4. Business Strategies and Development

12. Appendix

12.1. Research Methodology

12.2. Report Assumptions

12.3. Acronyms and Abbreviations